Cargando…

LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features

LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) are serine/threonine and tyrosine kinases and the only two members of the LIM kinase family. They play a crucial role in the regulation of cytoskeleton dynamics by controlling actin filaments and microtubule turnover, especially through the phosphorylati...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalonga, Elodie, Mosrin, Christine, Normand, Thierry, Girardin, Caroline, Serrano, Amandine, Žunar, Bojan, Doudeau, Michel, Godin, Fabienne, Bénédetti, Hélène, Vallée, Béatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000741/
https://www.ncbi.nlm.nih.gov/pubmed/36899941
http://dx.doi.org/10.3390/cells12050805
_version_ 1784903954674483200
author Villalonga, Elodie
Mosrin, Christine
Normand, Thierry
Girardin, Caroline
Serrano, Amandine
Žunar, Bojan
Doudeau, Michel
Godin, Fabienne
Bénédetti, Hélène
Vallée, Béatrice
author_facet Villalonga, Elodie
Mosrin, Christine
Normand, Thierry
Girardin, Caroline
Serrano, Amandine
Žunar, Bojan
Doudeau, Michel
Godin, Fabienne
Bénédetti, Hélène
Vallée, Béatrice
author_sort Villalonga, Elodie
collection PubMed
description LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) are serine/threonine and tyrosine kinases and the only two members of the LIM kinase family. They play a crucial role in the regulation of cytoskeleton dynamics by controlling actin filaments and microtubule turnover, especially through the phosphorylation of cofilin, an actin depolymerising factor. Thus, they are involved in many biological processes, such as cell cycle, cell migration, and neuronal differentiation. Consequently, they are also part of numerous pathological mechanisms, especially in cancer, where their involvement has been reported for a few years and has led to the development of a wide range of inhibitors. LIMK1 and LIMK2 are known to be part of the Rho family GTPase signal transduction pathways, but many more partners have been discovered over the decades, and both LIMKs are suspected to be part of an extended and various range of regulation pathways. In this review, we propose to consider the different molecular mechanisms involving LIM kinases and their associated signalling pathways, and to offer a better understanding of their variety of actions within the physiology and physiopathology of the cell.
format Online
Article
Text
id pubmed-10000741
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100007412023-03-11 LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features Villalonga, Elodie Mosrin, Christine Normand, Thierry Girardin, Caroline Serrano, Amandine Žunar, Bojan Doudeau, Michel Godin, Fabienne Bénédetti, Hélène Vallée, Béatrice Cells Review LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) are serine/threonine and tyrosine kinases and the only two members of the LIM kinase family. They play a crucial role in the regulation of cytoskeleton dynamics by controlling actin filaments and microtubule turnover, especially through the phosphorylation of cofilin, an actin depolymerising factor. Thus, they are involved in many biological processes, such as cell cycle, cell migration, and neuronal differentiation. Consequently, they are also part of numerous pathological mechanisms, especially in cancer, where their involvement has been reported for a few years and has led to the development of a wide range of inhibitors. LIMK1 and LIMK2 are known to be part of the Rho family GTPase signal transduction pathways, but many more partners have been discovered over the decades, and both LIMKs are suspected to be part of an extended and various range of regulation pathways. In this review, we propose to consider the different molecular mechanisms involving LIM kinases and their associated signalling pathways, and to offer a better understanding of their variety of actions within the physiology and physiopathology of the cell. MDPI 2023-03-04 /pmc/articles/PMC10000741/ /pubmed/36899941 http://dx.doi.org/10.3390/cells12050805 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Villalonga, Elodie
Mosrin, Christine
Normand, Thierry
Girardin, Caroline
Serrano, Amandine
Žunar, Bojan
Doudeau, Michel
Godin, Fabienne
Bénédetti, Hélène
Vallée, Béatrice
LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
title LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
title_full LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
title_fullStr LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
title_full_unstemmed LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
title_short LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
title_sort lim kinases, limk1 and limk2, are crucial node actors of the cell fate: molecular to pathological features
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000741/
https://www.ncbi.nlm.nih.gov/pubmed/36899941
http://dx.doi.org/10.3390/cells12050805
work_keys_str_mv AT villalongaelodie limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT mosrinchristine limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT normandthierry limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT girardincaroline limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT serranoamandine limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT zunarbojan limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT doudeaumichel limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT godinfabienne limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT benedettihelene limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures
AT valleebeatrice limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures